Trial intelligence / Profile preview

Bisacodyl Versus Placebo on Postoperative Bowel Motility in Elective Colorectal Surgery

NCT00509327Phase 4Completed

Sponsor
University Hospital Basel
Start
Nov 2004
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial in postoperative ileus (POI) comparing bisacodyl with placebo (2 arms). Primary endpoint: Time to recovery of gastrointestinal function (GI-3) at 10 days. Started Nov 2004; status: completed.

02

Drugs

bisacodyl
03

Conditions

postoperative ileus (POI)

Beyond the preview

Go deeper on NCT00509327.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00509327.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call